effect of whey permeate and yeast extract on metabolic activity of bifidobacterium animalis subsp. lactis bb 12
Authors
abstract
in fermented products containing bifidobacteria, factors such as organic acid concentration and b-galactosidase activity are important in the development of flavor and texture of final products. both the process conditions and medium components have significant effects on fluctuation of such factors. the effects of whey permeate powder and yeast extract concentrations, as nitrogen sources was investigated, on metabolic activity of bifidobacterium animalis subsp. lactis bb 12 in skim milk based media. development of organic acids, growth rate and b-galactosidase activity under uncontrolled ph conditions was also monitored. media with high concentrations of nitrogen sources showed maximum viable counts of b. animalis. the activity of b-galactosidase increased during the logarithmic phase and the initial stage of the stationary phase of growth and then decreased thereafter. increasing the yeast extract concentration resulted in an increase in the specific sugar consumption rate with concomitant reduction in formation of acetic acid and formic acid. consequently, the molar ratio of acetic acid to lactic acid was decreased. using limited amounts of nitrogen sources resulted in more organic acid production in the tested microorganism. during the early hours of fermentation in which the amounts of nitrogen levels were limited, the specific rate of b-glactosidase activity was very high. therefore, by evaluating the activity of this enzyme we can estimate the amount nutrient components in the medium.the production of succinic acid was observed during logarithmic and stationary phase in all fermentation media. citric acid that naturally exists in whey and skim milk powder was consumed during the stationary phase of growth by b. animalis and its consumption correlated significantly with the production of succinic acid at this stage.
similar resources
Effect of Whey Permeate and Yeast Extract on Metabolic Activity of Bifidobacterium Animalis Subsp. Lactis Bb 12
In fermented products containing Bifidobacteria, factors such as organic acid concentration and b-galactosidase activity are important in the development of flavor and texture of final products. Both the process conditions and medium components have significant effects on fluctuation of such factors. The effects of whey permeate powder and yeast extract concentrations, as nitrogen sources was i...
full textPolyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov.
The taxonomic standing of Bifidobacterium lactis and Bifidobacterium animalis was investigated using a polyphasic approach. Sixteen representatives of both taxa were found to be phenotypically similar and shared more than 70% DNA-DNA relatedness (76-100%), which reinforces the conclusions of previous studies in which B. lactis and B. animalis were considered to be one single species. However, t...
full textComplete genome sequence of Bifidobacterium animalis subsp. lactis BB-12, a widely consumed probiotic strain.
Bifidobacterium animalis subsp. lactis BB-12 is a commercially available probiotic strain used throughout the world in a variety of functional foods and dietary supplements. The benefits of BB-12 have been documented in a number of independent clinical trials. Determination of the complete genome sequence reveals a single circular chromosome of 1,942,198 bp with 1,642 predicted protein-encoding...
full textThe Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12®
This review presents selected data on the probiotic strain Bifidobacterium animalis subsp. lactis BB-12(®) (BB-12(®)), which is the world's most documented probiotic Bifidobacterium. It is described in more than 300 scientific publications out of which more than 130 are publications of human clinical studies. The complete genome sequence of BB-12(®) has been determined and published. BB-12(®) o...
full textAdministrAtion of BifidoBacterium animalis subsp. lactis bb-12 And XYLitoL WitH A noVEL pACifiEr in EArLY CHiLdHood
3
full textGenetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis.
All strains of Bifidobacterium animalis subsp. lactis described to date show medium level resistance to tetracycline. Screening of 26 strains from a variety of sources revealed the presence of tet(W) in all isolates. A transposase gene upstream of tet(W) was found in all strains, and both genes were cotranscribed in strain IPLAIC4. Mutants with increased tetracycline resistance as well as tetra...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of biotechnologyPublisher: national institute of genetic engineering and biotechnology
ISSN 1728-3043
volume 8
issue 1 2010
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023